Prostatic tumor relapse in patients with superficial bladder tumors: 15- year outcome Journal Article


Authors: Herr, H. W.; Donat, S. M.
Article Title: Prostatic tumor relapse in patients with superficial bladder tumors: 15- year outcome
Abstract: Purpose: We assessed the outcome of patients with superficial bladder tumors with relapse in the prostate and defined prognostic variables of survival. Materials and Methods: A cohort of 186 men with superficial bladder tumors was followed for 15 years. Tumor relapse in the prostate was classified as noninvasive (prostatic urethra and ducts) or invasive (stroma) with intraurethral or direct prostatic invasion. Bladder tumor stage at the time of prostatic relapse was defined as confined or not confined to the bladder. The end point of the study was disease specific survival. The effects of covariates on survival were estimated on multivariate analysis. Results: Of the 186 patients 72 (39%) had relapse in the prostate after a median followup of 28 months (range 3 to 216), including 45 (62%) with noninvasive prostatic tumor and 27 (38%) with stromal invasion. The survival rate was 82% in patients with prostatic urethra or duct involvement compared to 48% with stromal invasion. Intraurethral stromal invasion was associated with a 75% 15-year survival rate versus 9% for extravesical prostatic stromal invasion. Bladder tumor stage and prostatic stromal invasion were independent prognostic variables of survival. Conclusions: The prostate is a frequent site of tumor relapse in patients with superficial bladder tumors followed for 15 years. Prostatic relapse may portend tumor invasion in the bladder and stromal invasion in the prostate, which significantly reduce survival.
Keywords: cancer survival; survival rate; major clinical study; follow-up studies; bcg vaccine; bladder tumor; urinary bladder neoplasms; time factors; cancer invasion; prostatic neoplasms; tumor recurrence; prostate tumor; neoplasm invasiveness; bladder neoplasms; male genital tract tumor; humans; prognosis; human; male; priority journal; article
Journal Title: Journal of Urology
Volume: 161
Issue: 6
ISSN: 0022-5347
Publisher: Elsevier Science, Inc.  
Date Published: 1999-06-01
Start Page: 1854
End Page: 1857
Language: English
DOI: 10.1016/s0022-5347(05)68826-x
PUBMED: 10332452
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 16 August 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sherri M Donat
    174 Donat
  2. Harry W Herr
    594 Herr